SHR-9539

· Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-9539, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of SHR-9539 in Patients With Multiple Myeloma [Phase 1]